RE-ASSESSMENT OF THE RENAL HYDROSALINE DYSFUNCTION IN RATS BEARING THE WALKER-256 TUMOR

Sodium retention is a frequent effect of cancer in humans and animals, but the mechanism involved is not yet understood. In the Walker-256 tumor, sodium retention has been considered to be a late effect, secondary to retention in the tumor mass, and/or to adrenal hypertrophy. Normally, (in rats receiving single tumor implants), the development of different tumor systemic effects (TSE) such as anorexia, sodium and fluid retention, anemia and immune depression in rats is synchronous within each individual but random among individuals of a given group in which they appear 6-47 days, or more, after inoculation. In present study, multifocal simultaneous inoculations of tumor cells resulted in a rapid and synchronous initiation of TSE (in 3-4 days) in all rats when no local effects of metastases could mask the results. Sodium retention is a special tumor effect on Na+ balance and a very sensitive indicator of TSE initiation. The results from multifocally inoculated rats were averaged in each (sub-clinical (SubC), moderate (mCP) and grave (gCP)) clinical phase and compared to food-restricted (FR) rats. There was a significant, early decrease in urinary Na+ excretion during mCP when compared to SubC and FR. The renal sites involved were studied in awake, unrestrained animals by measuring of sodium, creatinine and lithium clearances. There was an initial increase in the absolute proximal (mCP: 21.4 ± 1.7 vs FR: 16.0 1.1 mmol/min/100 g b.w., p< 0.05) and postproximal (mCP: 11.1 ± 0.4 vs FR: 6.6 ± 0.4 mmol min/100g b.w., p <0.001) Na+ reabsorption, which were partially compensated for by a rise in glomerular filtration rate (mCP: 213 ± 11.4 vs FR: 162 ± 10.2μ L/min/100 g b.w., p < 0.01) and by a fall in fractional proximal Na+ reabsorption (mCP: 62.8 ± 2.2% vs FR: 70.1 ± 1.7%, p < 0.05), despite significant Na+ and fluid retention. The terminal phase of the illness (gCP) culminated with a marked decrease in creatinine clearance, suggesting a significant fall in renal function. The multifocal model proved useful for studying the initial TSE, since the sites of action would, in principle, be easy to identify. These observations may be of physiological interest since TSE may result from the abnormal production of physiological modulators.

[1]  M. A. Cruz-Höfling,et al.  Histologic and functional renal alterations caused by Bothrops moojeni snake venom in rats. , 1999, The American journal of tropical medicine and hygiene.

[2]  J. Gontijo,et al.  Effect of chronic metabolic acidosis on renal growth and renal sodium handling in uninephrectomized rats. , 1999, Renal failure.

[3]  A. W. Pratt,et al.  Food and water intakes and Walker tumor growth in rats with hypothalamic lesions. 1965. , 1965, Nutrition.

[4]  J. Gontijo,et al.  Reduced renal sodium excretion in Walker-256 tumor-bearing rats. , 1996, Acta physiologica, pharmacologica et therapeutica latinoamericana : organo de la Asociacion Latinoamericana de Ciencias Fisiologicas y [de] la Asociacion Latinoamericana de Farmacologia.

[5]  Q. Tahin,et al.  Variability and Discontinuity of the Pathognomonic Systemic Effects Caused by Walker 256 Tumor Progression in Rats , 1995, Tumori.

[6]  P. Twentyman The Basic Science of Oncology. 2nd Edition , 1993, British Journal of Cancer.

[7]  L. Tessitore,et al.  Humoral mediation for cachexia in tumour-bearing rats. , 1993, British Journal of Cancer.

[8]  S. Lowry Cancer cachexia revisited: old problems and new perspectives. , 1991, European journal of cancer.

[9]  L. Moldawer,et al.  Role of endogenous tumor necrosis factor alpha and interleukin 1 for experimental tumor growth and the development of cancer cachexia. , 1991, Cancer research.

[10]  G. Dibona Neural regulation of renal tubular sodium reabsorption and renin secretion. , 1985, Federation proceedings.

[11]  L. Morasca,et al.  Two Lines of Walker Carcinoma 256: Their Peculiarities and Different Interactions with the Host , 1983, Tumori.

[12]  T. Garland,et al.  Lymphoma presenting as anasarca. , 1981, Southern medical journal.

[13]  S. Garattini,et al.  Anorexia and cancer in animals and man. , 1980, Cancer treatment reviews.

[14]  T. Scherstén,et al.  Relationship of food intake, body composition, and tumor growth to host metabolism in nongrowing mice with sarcoma. , 1980, Cancer research.

[15]  G. L. Blackburn,et al.  The effect of cancer on nitrogen, electrolyte, and mineral metabolism , 1977, Cancer research.

[16]  A Theologides,et al.  Anorexia-producing intermediary metabolites. , 1976, The American journal of clinical nutrition.

[17]  F. Takacs Fluid and electrolyte problems in patients with advanced carcinoma. , 1975, The Medical clinics of North America.

[18]  S. Morrison Sodium and the cachexia and hypophagia of tumor growth. , 1974, Journal of the National Cancer Institute.

[19]  C. Saudek,et al.  The natriuretic effect of glucagon and its role in starvation. , 1973, The Journal of clinical endocrinology and metabolism.

[20]  S. Morrison Water intake and exchange and hydration of rats during growth of Walker 256 carcinoma. , 1971, Journal of the National Cancer Institute.

[21]  S. Morrison Effect of growth of a tumor on the regulation of water intake. , 1968, Journal of the National Cancer Institute.

[22]  A. Leaf,et al.  Some recent studies on the actions of neurohypophyseal hormones. , 1961, Progress in cardiovascular diseases.

[23]  R. E. Greenfield,et al.  Studies on the cachexia of tumor-bearing animals. I. Body weight changes, carcass composition, and metabolic studies. , 1961, Cancer research.

[24]  J. N. Toal,et al.  Sodium retention by rats bearing the Walker carcinosarcoma 256. , 1961, The American journal of physiology.

[25]  A. B. Craig,et al.  Body‐composition changes in patients with advanced cancer , 1957, Cancer.